Psychiatry Medical News about Fibromyalgia; Milnacipran

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fibromyalgia: Milnacipran: A New Treatment Option for Fibromyalgia
Practical Pain Management, 06/26/09

Mease PJ - On January 14, 2009 the Food and Drug Administration approved the use of SavellaTM (milnacipran) for the treatment of fibromyalgia. This third approved drug offers health care providers yet another treatment option for their fibromyaliga patients. Dr. Philip Mease’s detailed article covers the scientific specifics of Savella’s efficacy in a fibromyalgia treatment regimen and offers the promise of a better quality of life for people living with this chronic pain condition.

<< Previous
Essential fatty acids and attention-deficit–hyperactivity...

Next >>
Decreased serum levels of interleukin-2 and interleukin-6 in...

Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09 Relevance Score: 94%

Womens narratives on experiences of work ability and functioning in fibromyalgia
Musculoskeletal Care, 10/23/09 Relevance Score: 93%

General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study
BMC Public Health, 11/04/09 Relevance Score: 90%

Fibromyalgia: From treatment to rehabilitation
European Journal of Pain, 11/17/09 Relevance Score: 89%

Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention
Journal of Psychiatric and Mental Health Nursing, 11/16/09 Relevance Score: 89%